5-iodo-6-nitro-2-piperazinylquinoline has been researched along with paroxetine in 1 studies
Studies (5-iodo-6-nitro-2-piperazinylquinoline) | Trials (5-iodo-6-nitro-2-piperazinylquinoline) | Recent Studies (post-2010) (5-iodo-6-nitro-2-piperazinylquinoline) | Studies (paroxetine) | Trials (paroxetine) | Recent Studies (post-2010) (paroxetine) |
---|---|---|---|---|---|
6 | 0 | 0 | 4,257 | 1,031 | 1,031 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biegon, A; Enas, JD; Mathis, CA; Taylor, SE | 1 |
1 other study(ies) available for 5-iodo-6-nitro-2-piperazinylquinoline and paroxetine
Article | Year |
---|---|
[125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. I. In vitro studies.
Topics: Animals; Binding, Competitive; Carrier Proteins; Cell Membrane; Cerebral Cortex; Iodine Radioisotopes; Kinetics; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sodium Chloride | 1993 |